SCHEMBL15906227

SCHEMBL15906227

C[C@H]1CC[C@H](NC(=O)C2(CN)CC2)CC1

nearest known ligand 0.44

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
EPHX1 P07099 1/20 0.44
MME P08473 3/20 0.41
ALDH1A1 P00352 3/20 0.38
ADRA2A P08913 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
CSNK2A2 P19784 1/20 0.36
CSNK2A1 P68400 1/20 0.36
NPC1 O15118 5/20 0.36
RAB9A P51151 5/20 0.36
GAA P10253 1/20 0.35
TAS1R3 Q7RTX0 1/20 0.35
TAS1R1 Q7RTX1 1/20 0.35
TAS1R2 Q8TE23 1/20 0.35
PRNP P04156 1/20 0.35
SSTR4 P31391 1/20 0.34
POLB P06746 1/20 0.34
RECQL P46063 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14652106 0.82 MME (0.41) MMECSNK2A2CSNK2A1SSTR4
SCHEMBL14655006 0.79 MME (0.42) EPHX1MMECSNK2A2CSNK2A1SSTR4
SCHEMBL15906215 0.77 EPHX1 (0.48) EPHX1ALDH1A1ADRA2ASMN1; SMN2NPC1
SCHEMBL25019291 0.74 EPHX1 (0.50) EPHX1ALDH1A1ADRA2ASMN1; SMN2NPC1
SCHEMBL25676341 0.74 EPHX1 (0.50) EPHX1ALDH1A1ADRA2ASMN1; SMN2NPC1
SCHEMBL15906230 0.74 EPHX1 (0.50) EPHX1ALDH1A1ADRA2ASMN1; SMN2NPC1
SCHEMBL15906204 0.74 EPHX1 (0.50) EPHX1MMEALDH1A1ADRA2ASMN1; SMN2
SCHEMBL15906234 0.74 EPHX1 (0.50) EPHX1MMEALDH1A1ADRA2ASMN1; SMN2
SCHEMBL15906214 0.73 SMYD3 (0.54) EPHX1SMN1; SMN2NPC1RAB9AGAA
SCHEMBL13649892 0.73 SMYD3 (0.54) EPHX1SMN1; SMN2NPC1RAB9AGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8791257-B2 Substituted pyrrolotriazines as protein kinase inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2014-07-29 US disclosed